Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > This is what Dan said
View:
Post by Marky1 on Apr 07, 2021 4:21pm

This is what Dan said


I’m running the overall BD…and there are 3,000 US institutional investors; we’re knocking them off one by one...
Hes in full control and there's no one else I'd like to see guiding ATE to its golden futur
Comment by StockingUp21 on Apr 07, 2021 4:41pm
  Can you ask did this just start or happening since august and how many have they met with? I don't think it's working
Comment by MrMugsy on Apr 07, 2021 6:51pm
In August they were probably looking at making smaller deals - to bring in the cash.  Now we know they ended up partnering with China. They were not interested in discussing with Big Pharma at that time - I got the sense that ATE wasn't ready for those discussions. You are better off going to January's shareholder update and to the different virtual conferences Dan spoke at ... to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities